Hutch News
Results per Page:
Blood and Marrow Transplant Reunion returns to Fred Hutch
Hundreds gather in Seattle to celebrate life, science and cancer survivorship
Subverting the immunoproteasome in acute myeloid leukemia
From the Chapuis and Greenberg Labs, Clinical Research Division
Engaging cancer cells in a high stakes game of spot the imposter
From the Bradley Lab, Public Health Sciences and Basic Sciences Divisions
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
Novel transplant approach improves the odds for leukemia patients
Naïve T cells that lead to graft-vs.-host disease removed with magnets
Examining genomic features of infant acute myeloid leukemia
From the Meshinchi Lab, Clinical Research Division
Toward better cures for kids with AML: Q&A with Dr. Soheil Meshinchi
How researchers are developing personalized therapies for the deadliest childhood leukemia that have fewer side effects
Immunotherapy strategy for ovarian cancer aims to rewire a ‘kill switch’ to ramp-up signal
T cells bearing a new engineered protein boost immunotherapy’s effectiveness in laboratory models of AML, ovarian, pancreatic cancers
Unique set of tissue samples ‘ready to teach’ lessons about pediatric leukemia
Hutch-based repository leads to lifesaving treatments for young cancer patient
Bringing a leukemia treatment back to life with precision medicine
New research writes latest chapter in one drug's story
Remembering leukemia researcher Dr. Steve Collins
Among 'a lot of brilliant guys,' the leukemia clinician-researcher stood out for his science — and much more
Good News: Dr. Glenda Gray among Time magazine’s ‘100 most influential’
Celebrating faculty and staff achievements
A Q&A with immunotherapy researcher Dr. Rachel Perret
As part of a world-class immunotherapy research team, Perret is working her ‘dream job’ — trying to bring T-cell therapy to all who need it
Immunotherapy shows promise in preventing leukemia relapse
Group of 12 high-risk patients who received engineered T cells after bone marrow transplant still in remission
Umbilical cord blood transplant linked to lower relapse in high-risk leukemia patients
Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor
Good News at Fred Hutch
Dr. Roland Walter receives two grant awards for acute leukemia research; Dr. Jonathan Bricker to keynote behavioral therapy conference; Dr. Benjamin Anderson chairs NCCN committee that publishes clinical-practice guidelines for cervical cancer
'Have we come a long way'
A bench, a book and a mother’s memories of her son’s 1983 bone marrow transplant
Cord blood: 'The biggest blessing ever'
Cord blood: a lifesaving option for those in need of a transplant but cannot find a matched donor